CatalystPit

LGVNLongeveron Inc.

NASDAQ · Pharmaceutical Preparations
Last close $2.69 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-10-05 · Agafonova Nataliya (Chief Medical Officer) · OTHER
  • 2026-10-05 · Lehr Paul T (General Counsel, Secretary) · OTHER
  • 2026-10-05 · Jhaveri Nirav S. (Chief Financial Officer) · OTHER
  • 2026-10-05 · Willard Stephen H (Chief Executive Officer) · OTHER
  • 2026-10-05 · Blass Devin (CTO & SVP of CMC) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders43
Shares held5,272,965
Value$3.58M
As of quarter end2026-06-30
RECENT NEWS
  • Significant stock movers of September: Viking soars, Longeveron slides
  • Longeveron to Participate in Three Longevity/Aging Investment Conferences
  • Longeveron (LGVN) Heart Treatment Falls Short. Can a Strategic Review Preserve Value?
  • Longeveron's stem cell therapy fails mid-stage cardiovascular trial
  • Longeveron announces topline results from ELPIS II Phase 2b trial
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Longeveron Inc. (LGVN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit